Prévisions du marché du génome numérique en Amérique du Nord jusqu’en 2027 – Impact du COVID-19 et analyse régionale par produit (analyse ADN/ARN, puces de séquençage, instruments de séquençage et d’analyse, instruments de préparation d’échantillons, logiciels de séquençage et d’analyse) ; Application (diagnostic, agriculture, recherche universitaire, découverte de médicaments, personnalisation de la médecine, autre application) ; Utilisateur final (laboratoires de diagnostic et d\'investigation médico-légale, instituts de recherche universitaires, hôpitaux, autres utilisateurs finaux) et pays
Introduction au marché
Le génome numérique est un arrangement numérique avancé et complet de matériel génétique présent dans une cellule ou un organisme. Il s’agit d’un moyen plus simple d’accumuler des informations sur les maladies chroniques et utilisé par les experts pour avoir une meilleure idée des troubles génétiques. La génomique numérique traite des gènes et des connaissances. leurs rôles et vise à identifier et à traiter les facteurs à l’origine des troubles chroniques pour les résoudre. Cette technologie a déclenché une révolte dans la recherche et l’innovation centrées sur l’invention. biologie des systèmes pour accélérer la compréhension des systèmes génétiques les plus complexes.
Aperçu et dynamique du marché
Le marché nord-américain du génome numérique devrait atteindre 9 594,71 millions de dollars US d\'ici 2027, contre 4 999,94 millions de dollars US en 2019. Le marché devrait croître à un TCAC de 8,7 % entre 2019 et 2027. Des facteurs tels que le la prévalence croissante des maladies chroniques et le financement croissant de la génomique devraient stimuler la croissance du marché du génome numérique. Cependant, le marché est susceptible d\'être impacté par des facteurs de risque tels que les problèmes de sécurité et de confidentialité des données des patients au cours de la période de prévision.
Segments clés du marché
Segments clés du marché
En termes de produits, le segment des instruments de séquençage et d\'analyse représentait la plus grande part du marché du génome numérique en Amérique du Nord en 2019. Le segment des laboratoires de diagnostic et de médecine légale représentait la plus grande part du marché du génome numérique en Amérique du Nord. part du marché du génome numérique en Amérique du Nord, par utilisateur final, en 2019. En termes d\'application, le segment du diagnostic représentait la plus grande part du marché du génome numérique en Amérique du Nord en 2019.
Principales sources et sociétés répertoriées
Plusieurs sources primaires et secondaires majeures associées au rapport sur le marché du génome numérique en Amérique du Nord sont l\'Organisation mondiale de la santé (OMS), les centres du contrôle et de la prévention des maladies (CDC), de la Fédération internationale du diabète (FID), de l\'Institut national de recherche sur le génome humain (NHGRI), des statistiques de santé de l\'OCDE et autres.
Raisons d\'acheter rapport
- Il permet de comprendre le paysage du marché du génome numérique en Amérique du Nord et d\'identifier les segments du marché du génome numérique les plus susceptibles de garantir un rendement élevé.
- Il permet de comprendre le paysage du marché du génome numérique en Amérique du Nord et d\'identifier les segments du marché du génome numérique les plus susceptibles de garantir un rendement élevé. span>
- Il vous aide à garder une longueur d\'avance en comprenant le paysage concurrentiel en constante évolution du marché du génome numérique en Amérique du Nord.
- Cela aide planifier efficacement les fusions, les acquisitions et les accords de partenariat sur le marché du génome numérique en identifiant les segments de marché présentant les ventes probables les plus prometteuses
- Il facilite la prise de décision commerciale éclairée grâce à une analyse perspicace et complète du numérique Performances du marché du génome de divers segments relatifs au marché du génome numérique en Amérique du Nord.
- Il fournit des prévisions de revenus du marché du génome numérique du marché en fonction de divers segments pour la période de 2019 à 2027.
SEGMENTATION DU MARCHÉ DU GÉNOMÈNE NUMÉRIQUE EN AMÉRIQUE DU NORD
Par produit
- Instruments de séquençage et d\'analyse
- Analyse ADN/ARN
- Logiciel de séquençage et d\'analyse
- Puces de séquençage
- Instruments de préparation d\'échantillons
Par application
- Diagnostics
- Découverte de médicaments
- Recherche universitaire
- Médecine personnalisée
- Agriculture
- Autre
Par utilisateur final
- Laboratoires de diagnostic et de médecine légale
- Instituts de recherche universitaire
- Hôpitaux
- Autre
Par pays
- États-Unis
- Canada
- Mexique
Profils d\'entreprise
- BD
- THERMO FISHER SCIENTIFIC INC
- Illumina, Inc
- GenomeMe
- NanoString Technologies, Inc,
- GenMark Diagnostics, Inc
- Perkin Elmer, Inc.
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 North America Digital Genome Market – By Product
1.3.2 North America Digital Genome Market – By Application
1.3.3 North America Digital Genome Market– By End User
1.3.4 North America Digital Genome Market – By Country
2. North America Digital Genome Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. North America Digital Genome Market – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 Digital Genome Market - North America PEST Analysis
4.3 Expert Opinion
5. North America Digital Genome Market - Key Market Dynamics
5.1 Key Market Drivers
5.1.1 Growing Funding for Genomics
5.1.2 Increasing Prevalence of Chronic Diseases
5.2 Key Market Restraints
5.2.1 Security and Confidentiality Issue
5.3 Key Market Opportunities
5.3.1 Increasing Technological Advancement in Digital Genome Field
5.4 Future Trends
5.4.1 Increasing Demand for Personalized Medicines
5.5 Impact Analysis
6. Digital Genome Market – North America Analysis
6.1 North America Digital Genome Market Revenue Forecasts and Analysis
7. North America Digital Genome Market Analysis and Forecasts To 2027 – By Product
7.1 Overview
7.2 North America Digital Genome Market, By Product 2019 & 2027 (%)
7.2.1 North America Digital Genome Market Revenue and Forecasts to 2027, By Product (US$ Mn)
7.3 DNA/RNA Analysis
7.3.1 Overview
7.3.2 North America DNA/RNA Analysis Market Revenue and Forecast to 2027 (US$ Mn)
7.4 Sequencing and Analyzer Instruments
7.4.1 Overview
7.4.1.1 North America Sequencing and Analyzer Instruments Market Revenue and Forecasts to 2027 (US$ Mn)
7.5 Sequencing and Analysis Software
7.5.1 Overview
7.5.2 North America Sequencing and Analysis Software Market Revenue and Forecast to 2027 (US$ Mn)
7.6 Sequencing Chips
7.6.1 Overview
7.6.2 North America Sequencing Chips Market Revenue and Forecast to 2027 (US$ Mn)
7.7 Sample Prep Instruments
7.7.1 Overview
7.7.2 North America Sample Prep Instruments Market Revenue and Forecast to 2027 (US$ Mn)
8. North America Digital Genome Market Analysis and Forecasts To 2027 – By Application
8.1 Overview
8.2 North America Digital Genome Market, By Application 2019 & 2027 (%)
8.2.1 North America Digital genome Market Revenue and Forecasts to 2027, By Application (US$ Mn)
8.3 Diagnostics
8.3.1 Overview
8.3.2 North America Diagnostics Market Revenue and Forecast to 2027 (US$ Mn)
8.4 Drug Discovery
8.4.1 Overview
8.4.2 North America Drug Discovery Market Revenue and Forecasts to 2027 (US$ Mn)
8.5 Academic Research
8.5.1 Overview
8.5.2 North America Academic Research Market Revenue and Forecasts to 2027 (US$ Mn)
8.6 Personalized Medicine
8.6.1 Overview
8.6.2 North America Personalized Medicine Market Revenue and Forecasts to 2027 (US$ Mn)
8.7 Agricultural
8.7.1 Overview
8.7.2 North America Agricultural Market Revenue and Forecasts to 2027 (US$ Mn)
8.8 Others
8.8.1 Overview
8.8.2 North America Others Market Revenue and Forecasts to 2027 (US$ Mn)
9. North America Digital Genome Market Analysis – By End-User
9.1 Overview
9.2 North America Digital Genome Market, By End-User 2019-2027 (%)
9.2.1 North America Digital Genome Market Revenue and Forecasts to 2027, By End-User (US$ Mn)
9.3 Diagnostics and Forensic Labs
9.3.1 Overview
9.3.2 North America Diagnostics and Forensic Labs Market Revenue and Forecasts to 2027 (US$ Mn)
9.4 Academic Research Institutes
9.4.1 Overview
9.4.2 North America Academic Research Institutes Market Revenue and Forecasts to 2027 (US$ Mn)
9.5 Hospitals
9.5.1 Overview
9.5.2 North America Hospitals Market Revenue and Forecasts to 2027 (US$ Mn)
9.6 Others
9.6.1 Overview
9.6.2 North America Others Market Revenue and Forecasts to 2027 (US$ Mn)
10. Digital genome Market Revenue and Forecasts To 2027 – Geographical Analysis
10.1 North America Digital genome Market Revenue and Forecasts To 2027
10.1.1 Overview
10.1.2 North America: Digital Genome Market – Revenue and Forecast to 2027 (USD Million)
10.1.3 North America: Digital Genome Market, by Product, 2018–2027 (USD Million)
10.1.4 North America: Digital Genome Market, by Application , 2018–2027 (USD Million)
10.1.5 North America: Digital Genome Market, by End User , 2018–2027 (USD Million)
10.1.6 North America: Digital Genome Market, by Country, 2019 & 2027 (%)
10.1.7 US: Digital Genome Market – Revenue and Forecast to 2027 (USD Million)
10.1.7.1 US: Digital Genome Market – Revenue and Forecast to 2027 (USD Million)
10.1.7.2 US: Digital Genome Market, by Product, 2018–2027 (USD Million)
10.1.7.3 US: Digital Genome Market, by Application, 2018–2027 (USD Million)
10.1.7.4 US: Digital Genome Market, by End User , 2018–2027 (USD Million)
10.1.8 Canada: Digital Genome Market – Revenue and Forecast to 2027 (USD Million)
10.1.8.1 Canada: Digital Genome Market – Revenue and Forecast to 2027 (USD Million)
10.1.8.2 Canada: Digital Genome Market, by Product, 2018–2027 (USD Million)
10.1.8.3 Canada: Digital Genome Market, by Application , 2018–2027 (USD Million)
10.1.8.4 Canada: Digital Genome Market, by End User , 2018–2027 (USD Million)
10.1.9 Mexico: Digital Genome Market – Revenue and Forecast to 2027 (USD Million)
10.1.9.1 Mexico: Digital Genome Market – Revenue and Forecast to 2027 (USD Million)
10.1.9.2 Mexico: Digital Genome Market, by Product, 2018–2027 (USD Million)
10.1.9.3 Mexico: Digital Genome Market, by Application , 2018–2027 (USD Million)
10.1.9.4 Mexico: Digital Genome Market, by End User , 2018–2027 (USD Million)
11. Impact of COVID-19 Pandemic on North America Digital Genome Market
11.1 North America: Impact Assessment of COVID-19 Pandemic
12. Company Profiles
12.1 THERMO FISHER SCIENTIFIC INC
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Illumina, Inc.
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 GenomeMe
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 NanoString Technologies, Inc.
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 BD
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 GenMark Diagnostics, Inc.
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Perkin Elmer, Inc.
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
13. Appendix
13.1 About The Insight Partners
13.2 Glossary of Terms
LIST OF TABLES
Table 1. North America Digital Genome Market Revenue and Forecasts To 2027, By Product (US$ Mn)
Table 2. North America Digital genome Market Revenue and Forecasts To 2027, By Application (US$ Mn)
Table 3. North America Digital Genome Market Revenue and Forecasts To 2027, By End-User (US$ Mn)
Table 4. North America Digital Genome Market, by Product – Revenue and Forecast to 2027 (USD Million)
Table 5. North America Digital Genome Market, by Application– Revenue and Forecast to 2027 (USD Million)
Table 6. North America Digital Genome Market, by End User– Revenue and Forecast to 2027 (USD Million)
Table 7. US Digital Genome Market, by Product – Revenue and Forecast to 2027 (USD Million)
Table 8. US Digital Genome Market, by Application– Revenue and Forecast to 2027 (USD Million)
Table 9. US Digital Genome Market, by End User– Revenue and Forecast to 2027 (USD Million)
Table 10. Canada Digital Genome Market, by Product – Revenue and Forecast to 2027 (USD Million)
Table 11. Canada Digital Genome Market, by Application– Revenue and Forecast to 2027 (USD Million)
Table 12. Canada Digital Genome Market, by End User– Revenue and Forecast to 2027 (USD Million)
Table 13. Mexico Digital Genome Market, by Product – Revenue and Forecast to 2027 (USD Million)
Table 14. Mexico Digital Genome Market, by Application– Revenue and Forecast to 2027 (USD Million)
Table 15. Mexico Digital Genome Market, by End User– Revenue and Forecast to 2027 (USD Million)
Table 16. Glossary of Terms, Digital Genome Market
LIST OF FIGURES
Figure 1. Digital Genome Market Segmentation
Figure 2. North America Digital Genome Market Overview
Figure 3. The Sequencing and Analyzer Instruments Segment Held Largest Share of Digital Genome Market
Figure 4. US is Expected to Show Remarkable Growth During the Forecast Period
Figure 5. North America Digital Genome Market - Leading Country Markets (US$ Mn)
Figure 6. Digital Genome Market - North America PEST Analysis
Figure 7. Digital Genome Market Impact Analysis of Driver and Restraints
Figure 8. North America Digital Genome Market – Revenue Forecasts and Analysis – 2019- 2027
Figure 9. North America Digital Genome Market, By Product 2019 & 2027 (%)
Figure 10. North America DNA/RNA Analysis Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 11. North America Sequencing and Analyzer Instruments Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 12. North America Sequencing and Analysis Software Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 13. North America Sequencing Chips Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 14. North America Sample Prep Instruments Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 15. North America Digital Genome Market, By Application 2019 & 2027 (%)
Figure 16. North America Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 17. North America Drug Discovery Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 18. North America Academic Research Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 19. North America Personalized Medicine Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 20. North America Agricultural Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 21. North America Others Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 22. North America Digital Genome Market, by End-User 2019 & 2027 (%)
Figure 23. North America Diagnostics and Forensic Labs Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 24. North America Academic Research Institutes Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 25. North America Hospitals Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 26. North America Others Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 27. North America: Digital Genome Market, by Key Country – Revenue (2019) (USD Million)
Figure 28. North America Digital Genome Market Revenue and Forecast to 2027 (USD Million)
Figure 29. North America: Digital Genome Market, by Country, 2019 & 2027 (%)
Figure 30. US: Digital Genome Market – Revenue and Forecast to 2027 (USD Million)
Figure 31. Canada: Digital Genome Market – Revenue and Forecast to 2027 (USD Million)
Figure 32. Mexico: Digital Genome Market – Revenue and Forecast to 2027 (USD Million)
Figure 33. Impact of COVID-19 Pandemic in North American Country Markets
The List of Companies - North America Digital Genome Market
- BD
- THERMO FISHER SCIENTIFIC INC
- Illumina, Inc
- GenomeMe
- NanoString Technologies, Inc,
- GenMark Diagnostics, Inc
- Perkin Elmer, Inc.
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the North America digital genome market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the North America digital genomemarket, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.